|
2024
|
Invention
|
Antibody targeting cd22 and cd79b.
Provided herein are multispecific antibodies, that bind to CD... |
|
|
Invention
|
Multi-specific immune targeting molecules and uses thereof.
Provided herein are trispecific anti... |
|
|
Invention
|
Methods of treating crohn's disease with anti-il23 specific antibody.
A method of treating Crohn... |
|
|
Invention
|
Accessories for drug injection devices. Provided herein are accessories for drug injection device... |
|
|
Invention
|
Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis.
... |
|
|
Invention
|
Methods and materials for scalable 3d cellular redifferentiation. Methods and materials for the c... |
|
|
Invention
|
Safe and effective method of treating lupus with anti-il/il23 antibody.
A method of treating act... |
|
|
Invention
|
Methods for producing anti-tnf antibody compositions.
Presented here are methods for producing a... |
|
|
Invention
|
Method and apparatus for facilitating access to an eye. An ocular access instrument (20) includes... |
|
|
Invention
|
Immune modulation and treatment of solid tumors with antibodies that specifically bind cd38.
The... |
|
|
Invention
|
Methods of treating non-small cell lung cancer. The present disclosure provides methods for treat... |
|
|
Invention
|
Bioengineered immunomodulatory fusion protein compositions. Provided herein are, inter alia, mate... |
|
|
Invention
|
Anti-cd20 x anti-cd28 combination therapies. Provided herein are novel anti-CD20 x anti-CD28 anti... |
|
|
Invention
|
Compositions and methods for modulating delta gamma chain mediated immunity.
Provided herein, in... |
|
|
Invention
|
Trispecific antibody targeting cd79b, cd20, and cd3.
Provided herein are multispecific antibodie... |
|
|
Invention
|
Gucy2c antibodies and uses thereof.
Disclosed herein are antibodies or antigen binding fragments... |
|
|
Invention
|
Enpp3 and cd3 binding agents and methods of use thereof. The present disclosure provides ENPP3 bi... |
|
|
Invention
|
Stabilized cd3 antigen binding agents and methods of use thereof. Stabilized CD3 antigen binding ... |
|
|
Invention
|
Gucy2c antibodies and uses thereof. Disclosed herein are antibodies or antigen binding fragments ... |
|
|
Invention
|
Syringe accessories. Provided herein are syringe accessories and methods of use thereof with syri... |
|
|
Invention
|
Molecules that bind to mutant calreticulin and uses thereof. The present disclosure relates to an... |
|
|
Invention
|
Materials and methods for cell growth. Materials, methods, molecules, and systems including antib... |
|
|
Invention
|
Prepared dehydrated, desiccated and/or lyophilized culture containers for t cell activation and m... |
|
|
Invention
|
Methods for treating multiple myeloma. Embodiments of the present invention relate to methods of ... |
|
|
Invention
|
Anti-cd38 antibodies for treatment of light chain amyloidosis and other cd38-positive hematologic... |
|
|
Invention
|
Combination therapies with anti-cd38 antibodies.
The present invention relates to combination th... |
|
|
Invention
|
Manufacturing methods for producing anti-tnf antibody compositions.
The present invention relate... |
|
|
Invention
|
Dosing regimen for therapies comprising bispecific antiegfr/c-met antibodies. Provided are method... |
|
|
Invention
|
Materials and methods for viral engineering. The present invention provides materials and methods... |
|
|
Invention
|
Drug delivery device. In one example, a drug delivery system, such as an on-body or off-body deli... |
|
|
Invention
|
Pharmaceutical compositions comprising a bispecific bcma/cd3 antibody at high concentration.
Pro... |
|
|
Invention
|
Methods for treating multiple myeloma.
Embodiments of the present invention relate to methods of... |
|
|
Invention
|
Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulator... |
|
|
Invention
|
Generation of human pluripotent stem cell derived functional beta cells showing a glucose-depende... |
|
2023
|
Invention
|
Bcma-targeted car-t cell therapy for multiple myeloma. Provided herein are methods of treating a ... |
|
|
Invention
|
Iimmunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their use... |
|
2022
|
Invention
|
Il-23 specific antibodies for the treatment of systemic sclerosis. A method of treating systemic ... |
|
|
Invention
|
Orchestrated personalized therapy systems and methods.
Disclosed are devices, systems, methods, ... |
|
|
Invention
|
Macrocyclic compounds and methods of making the same.
The present invention is directed to the p... |
|
|
Invention
|
Compositions and methods for the modulation of beta chain-mediated immunity.
Anti-Vβ17 antibodie... |
|
|
Invention
|
Biosynthetic monovalent binding molecules with enhanced effector functions.
Provided herein, in ... |
|
|
Invention
|
Cd33 x vd2 multispecific antibodies for the treatment of cancer.
The invention relates to multis... |
|
|
Invention
|
Anti-vegfr1 antibodies and their uses.
Disclosed herein are antibodies or antigen binding fragme... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor.
The present invention relates to novel cyclic pep... |
|
|
Invention
|
Materials and methods for enhanced detection and screening of molecules of therapeutic potential.... |
|
2019
|
G/S
|
Operating an online-marketplace featuring cell and gene therapy treatments and services; business... |
|
2016
|
G/S
|
Software as a service (SAAS) services, namely, hosting software for use by others for ordering, t... |
|
2008
|
G/S
|
Pharmaceutical and veterinary preparations, pharmaceutical preparations for the prevention and tr... |
|
2007
|
G/S
|
patient assistance program, namely, financial assistance for patients receiving pharmaceutical pr... |
|
2003
|
G/S
|
Pharmaceutical for the treatment of autoimmune diseases and autoimmune disorders. |
|
2002
|
G/S
|
pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders |
|
2001
|
G/S
|
Medical device used to infuse pharmaceuticals. |
|
|
G/S
|
Pharmaceutical for treatment of autoimmune diseases and disorders. |
|
1998
|
G/S
|
Pharmaceutical and medical preparations and substances; pharmaceutical compositions for the treat... |
|
|
G/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders. |
|
|
G/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders |
|
1996
|
G/S
|
Pharmaceutical preparations and products. |
|
1994
|
G/S
|
Pharmaceutical preparations for prevention and treatment of disease of the circulatory system. |
|
|
G/S
|
pharmaceutical preparations for the prevention and treatment of diseases of the circulatory system |
